Search Results for: 2014

Celltex on the move: full copy of letter to patients, new slogan, and new video

I requested of Celltex a copy of the email/letter that they recently sent to their patients. They kindly provided me a copy, which you can read here (snap shot of beginning is above). Thank you, Celltex! I also asked Celltex some questions regarding their plan to start having patients treated in Mexico. Unfortunately, they have […]

Celltex on the move: full copy of letter to patients, new slogan, and new video Read More »

Some important rules for Stem Cell Person of the Year Award: please read carefully

My blog’s Stem Cell Person of the Year Award process has gotten off to a very exciting start. I have an amazing bunch of nominees and about 1000 votes were case in about 12 hours. Based on some discussions with people yesterday, I believe a few clarifications are needed about the process: The award is

Some important rules for Stem Cell Person of the Year Award: please read carefully Read More »

Tool to easily search for a stem cell clinical trial for your disease

clinicaltrials.gov_

Clinicaltrials.gov is where you want to go for finding a certain clinical trial and studies. Note that this U.S. database Clinicaltrials.gov includes international trials. It is a very powerful tool! Check it out here to do your own searches. Also follow me on Twitter for all the latest info and expert analysis: http://twitter.com/pknoepfler and this patient’s

Tool to easily search for a stem cell clinical trial for your disease Read More »

The dangerous myth of email privacy: a lesson from scientists who were spied on by the FDA

FDA

A major scandal has erupted further regarding FDA monitoring of its scientists’ emails as reported by the NY Times. The FDA spied on the emails of its own scientists and other scientists. Some of the emails also involved correspondence with Congress and even the White House. Regardless of one’s position on what the FDA did,

The dangerous myth of email privacy: a lesson from scientists who were spied on by the FDA Read More »

Will the real Don Margolis please stand up: ties to Grekos who is charged in stem cell fatalities

Zannos_Grekos

Dr. Zannos Grekos has administered so-called stem cell-based treatments to patients, at least two of whom have died following treatment in the last couple years. It is an understatement to say that Grekos is in serious hot water with various authorities at the state and federal levels. In the case of a 77-year old man

Will the real Don Margolis please stand up: ties to Grekos who is charged in stem cell fatalities Read More »

Why all the fuss about SCNT-derived ES cell paper?

This past week a paper came out in Nature that reported the successful production of human ES cells using somatic cell nuclear transfer (SCNT) technology. It is no exaggeration to say that this paper generated massive international media coverage, in part because of the links between this technology and the potential for human cloning, both

Why all the fuss about SCNT-derived ES cell paper? Read More »

Stem Cell Clinical Trials Part I: Geron VP Lebkoswki speaking today in Seattle

Geron-300x2212

We’ve all been closely following Geron and its work on ES cells. This morning there was a fantastic session here at the ASGCT meeting in Seattle on Clinical Trials on Stem Cells. Talk by Geron One of the speakers was Geron VP, Jane Lebkoswki, PhD: Development of Human Embryonic Stem Cell-Based Therapies for Treatment of

Stem Cell Clinical Trials Part I: Geron VP Lebkoswki speaking today in Seattle Read More »

FDA approves Advanced Cell Technology second stem cell trial for blindness

Advanced Cell Technology (ACT) announced that the FDA has approved their second human ES cell-based clinical trial, a combined Phase I/II, for the treatment of blindness. Advanced Cell Technology As a result, soon ACT will have two active, human ES cell-based clinical trials, both using the same human ES cell-based drug. The aim of the

FDA approves Advanced Cell Technology second stem cell trial for blindness Read More »